Health Care

Healthcare HR

Our office plays an important role in ensuring that quality health care is accessible and affordable for all Rhode Islanders.

From serving as a regulatory authority in major hospital transactions to advocating on behalf of all Rhode Islanders, the Office continues to make important strides when it comes to expanding our role in health care.

    Here are a few recent highlights:

    • We put affordability front and center when insurance companies pushed to increase insurance rates during the middle of a massive public health crisis.
    • We worked to ensure that vaccine distribution was guided by public health and done in accordance with the guidelines provided by the CDC, and that entities charged with vaccine administration did  so in an equitable and transparent manner.
    • We took steps to build a top-notch healthcare team in the Office to execute our crucial role under the Hospital Conversions Act (HCA) as one of the main regulators of potential hospital mergers in the state.
    • We introduced legislation passed by  the General Assembly that strengthened the Office’s oversight role under the HCA by adding antitrust review, extending the monitoring period after  a transaction, increasing the monetary fine for violations, and simplifying the judicial review process.

    The Rhode Island Office of Attorney General reviews proposed hospital conversions pursuant to the Hospital Conversions Act, R.I. Gen. Laws § 23-17.14, et. seq.

    Hospital Conversion or Merger Initial Application

    Please call the Office of the Health Care Advocate at (401) 274-4400 for more information.

    Rhode Island Law permits parties subject to the HCA to withhold proprietary business information as confidential, subject to review by the Office of the Attorney General. If parties request certain information remain confidential, our Office will perform a detailed review of their request to determine if they are entitled by law to withhold that information. If parties do not request non-disclosure, our Office will not review for confidentiality. If parties disagree with our Office’s determination, they may seek court review.

    AG Decision Denying Merger Application

    AG Presentation Outlining Decision

     

    Application_public_documents

    Attorney General and Director of RIDOH deem Lifespan CNE merger application complete under the Hospital Conversions Act

    RIAG and RIDOH make Lifespan-CNE merger application available to the public, schedule public comment meetings

    Find application here under Recent HCA Reviews

    Audio from January 20, 2022 Public Comment Meeting

    Transcript of January 20, 2022 Public Comment Meeting

    Audio from January 26, 2022 Public Comment Meeting

    Transcript of January 26, 2022 Public Comment Meeting

    Access Public Written Comments here

    Expert Report: Pflum

    Expert Report: Burns

    Expert Report: Veralon

    Public Exhibits
    Additional Public Exhibits

    Public Exhibits

    Public Exhibits
    Confidential Exhibits Deemed Public
    Supplemental submission 8/11/20
    First Set of Supplemental Questions and Responses
    Second Set of Supplemental Questions and Responses
    Third Set of Supplemental Questions and Responses
    Fourth Set of Supplemental Questions and Responses
    Fifth Set of Supplemental Questions and Responses
    Statements under oath transcripts and related confidentiality determinations

    RSM Agreement Fully Executed 8.23.21 - Redacted

    Chamber Inc.; Ivy Holdings Inc.; Ivy Intermediate Holdings, Inc.; Prospect Medical Holdings, Inc.; Prospect East Holdings, Inc.; Prospect East Hospital Advisory Services, LLC; Prospect CharterCARE, LLC; Prospect CharterCARE SJHSRI, LLC; Prospect CharterCA.

     

    Rhode Island Law permits parties subject to the HCA to withhold proprietary business information as confidential, subject to review by the Office of the Attorney General. If parties request certain information remain confidential, our Office will perform a detailed review of their request to determine if they are entitled by law to withhold that information. If parties do not request non-disclosure, our Office will not review for confidentiality. If parties disagree with our Office’s determination, they may seek court review.

    Final RIAG Chamber Ivy Report for QE 09 30 2022 - Redacted

    Final RIAG Chamber Ivy Report for QE 06 30 2022 - Redacted

    Final RIAG Chamber Ivy Report for QE 03 31 2022 - Redacted

    Final RIAG Chamber Ivy Report for QE 12 31 2021 - Redacted

    Final RIAG Chamber Ivy Report for QE 09 30 2021 - Redacted

    Final RIAG Chamber Ivy Report for YE 09 30 2021 - Redacted

     

    Information submitted to the Office of the Attorney General under the Hospital Conversions Act as part of an application or ongoing monitoring is subject to a detailed confidentiality review by the Office before being publicly released. Reviews are conducted on an individualized basis, taking into account the context, facts, and circumstances of each transaction or monitoring. The Attorney General and Transacting Parties have agreed to make the information in the below documents public without redaction, notwithstanding the fact that, in some instances, documents could have been maintained as confidential.

    RIAG Chamber Ivy CAPEX reduction report 10.18.21